These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 37488090)

  • 1. Galidesivir Triphosphate Promotes Stalling of Dengue-2 Virus Polymerase Immediately Prior to Incorporation.
    Deshpande S; Huo W; Shrestha R; Sparrow K; Wood JM; Evans GB; Harris LD; Kingston RL; Bulloch EMM
    ACS Infect Dis; 2023 Aug; 9(8):1658-1673. PubMed ID: 37488090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-nucleoside Inhibitors of Zika Virus RNA-Dependent RNA Polymerase.
    Gharbi-Ayachi A; Santhanakrishnan S; Wong YH; Chan KWK; Tan ST; Bates RW; Vasudevan SG; El Sahili A; Lescar J
    J Virol; 2020 Oct; 94(21):. PubMed ID: 32796069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An E460D Substitution in the NS5 Protein of Tick-Borne Encephalitis Virus Confers Resistance to the Inhibitor Galidesivir (BCX4430) and Also Attenuates the Virus for Mice.
    Eyer L; Nougairède A; Uhlířová M; Driouich JS; Zouharová D; Valdés JJ; Haviernik J; Gould EA; De Clercq E; de Lamballerie X; Ruzek D
    J Virol; 2019 Aug; 93(16):. PubMed ID: 31142664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of Ribonucleotide 5'-Triphosphate Analogs as Potential Inhibitors of Zika Virus RNA-Dependent RNA Polymerase by Using Nonradioactive Polymerase Assays.
    Lu G; Bluemling GR; Collop P; Hager M; Kuiper D; Gurale BP; Painter GR; De La Rosa A; Kolykhalov AA
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 27993851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-Phenylpyridine-3-Carboxamide and 6-Acetyl-1H-Indazole Inhibit the RNA Replication Step of the Dengue Virus Life Cycle.
    Sow AA; Pahmeier F; Ayotte Y; Anton A; Mazeaud C; Charpentier T; Angelo L; Woo S; Cerikan B; Falzarano D; Abrahamyan L; Lamarre A; Labonté P; Cortese M; Bartenschlager R; LaPlante SR; Chatel-Chaix L
    Antimicrob Agents Chemother; 2023 Feb; 67(2):e0133122. PubMed ID: 36700643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zika Virus Subgenomic Flavivirus RNA Generation Requires Cooperativity between Duplicated RNA Structures That Are Essential for Productive Infection in Human Cells.
    Pallarés HM; Costa Navarro GS; Villordo SM; Merwaiss F; de Borba L; Gonzalez Lopez Ledesma MM; Ojeda DS; Henrion-Lacritick A; Morales MA; Fabri C; Saleh MC; Gamarnik AV
    J Virol; 2020 Aug; 94(18):. PubMed ID: 32581095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and Safety of the Nucleoside Analog Antiviral Drug Galidesivir Administered to Healthy Adult Subjects.
    Mathis A; Collins D; Dobo S; Walling DM; Sheridan WP; Taylor R
    Clin Pharmacol Drug Dev; 2022 Apr; 11(4):467-474. PubMed ID: 35182042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variability in Susceptibility to Type I Interferon Response and Subgenomic RNA Accumulation Between Clinical Isolates of Dengue and Zika Virus From Oaxaca Mexico Correlate With Replication Efficiency in Human Cells and Disease Severity.
    Castro-Jiménez TK; Gómez-Legorreta LC; López-Campa LA; Martínez-Torres V; Alvarado-Silva M; Posadas-Mondragón A; Díaz-Lima N; Angulo-Mendez HA; Mejía-Domínguez NR; Vaca-Paniagua F; Ávila-Moreno F; García-Cordero J; Cedillo-Barrón L; Aguilar-Ruíz SR; Bustos-Arriaga J
    Front Cell Infect Microbiol; 2022; 12():890750. PubMed ID: 35800385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A direct-acting antiviral drug abrogates viremia in Zika virus-infected rhesus macaques.
    Lim SY; Osuna CE; Best K; Taylor R; Chen E; Yoon G; Kublin JL; Schalk D; Schultz-Darken N; Capuano S; Safronetz D; Luo M; MacLennan S; Mathis A; Babu YS; Sheridan WP; Perelson AS; Whitney JB
    Sci Transl Med; 2020 Jun; 12(547):. PubMed ID: 32522808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutathionylation of dengue and Zika NS5 proteins affects guanylyltransferase and RNA dependent RNA polymerase activities.
    Saisawang C; Kuadkitkan A; Auewarakul P; Smith DR; Ketterman AJ
    PLoS One; 2018; 13(2):e0193133. PubMed ID: 29470500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A flavivirus-inducible gene expression system that modulates broad-spectrum antiviral activity against dengue and Zika viruses.
    Weng SC; Zhou YX; Shiao SH
    Insect Biochem Mol Biol; 2022 Mar; 142():103723. PubMed ID: 35074522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of AT-752, a Double Prodrug of a Guanosine Nucleotide Analog with
    Good SS; Shannon A; Lin K; Moussa A; Julander JG; La Colla P; Collu G; Canard B; Sommadossi JP
    Antimicrob Agents Chemother; 2021 Oct; 65(11):e0098821. PubMed ID: 34424050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical characterization of the inhibition of the dengue virus RNA polymerase by beta-d-2'-ethynyl-7-deaza-adenosine triphosphate.
    Latour DR; Jekle A; Javanbakht H; Henningsen R; Gee P; Lee I; Tran P; Ren S; Kutach AK; Harris SF; Wang SM; Lok SJ; Shaw D; Li J; Heilek G; Klumpp K; Swinney DC; Deval J
    Antiviral Res; 2010 Aug; 87(2):213-22. PubMed ID: 20470829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification of Dengue and Zika Virus Non-structural Protein 5 for Crystallization and Screening of Antivirals.
    Gharbi-Ayachi A; El Sahili A; Lescar J
    Methods Mol Biol; 2022; 2409():47-61. PubMed ID: 34709635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance to a Nucleoside Analog Antiviral Drug from More Rapid Extension of Drug-Containing Primers.
    Chen H; Lawler JL; Filman DJ; Hogle JM; Coen DM
    mBio; 2021 Feb; 12(1):. PubMed ID: 33563814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sophoraflavenone G Restricts Dengue and Zika Virus Infection via RNA Polymerase Interference.
    Sze A; Olagnier D; Hadj SB; Han X; Tian XH; Xu HT; Yang L; Shi Q; Wang P; Wainberg MA; Wu JH; Lin R
    Viruses; 2017 Oct; 9(10):. PubMed ID: 28972551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiviral activity of the natural alkaloid anisomycin against dengue and Zika viruses.
    Quintana VM; Selisko B; Brunetti JE; Eydoux C; Guillemot JC; Canard B; Damonte EB; Julander JG; Castilla V
    Antiviral Res; 2020 Apr; 176():104749. PubMed ID: 32081740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An update on the progress of galidesivir (BCX4430), a broad-spectrum antiviral.
    Julander JG; Demarest JF; Taylor R; Gowen BB; Walling DM; Mathis A; Babu YS
    Antiviral Res; 2021 Nov; 195():105180. PubMed ID: 34551346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Dengue Virus Nonstructural Protein 1 (NS1) Interacts with the Putative Epigenetic Regulator DIDO1 to Promote Flavivirus Replication in Mosquito Cells.
    Caraballo GI; Rosales R; Viettri M; Castillo JM; Cruz R; Ding S; Greenberg HB; Ludert JE
    J Virol; 2022 Jun; 96(12):e0070422. PubMed ID: 35652656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of Galidesivir in a Hamster Model of SARS-CoV-2.
    Taylor R; Bowen R; Demarest JF; DeSpirito M; Hartwig A; Bielefeldt-Ohmann H; Walling DM; Mathis A; Babu YS
    Viruses; 2021 Dec; 14(1):. PubMed ID: 35062212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.